All Posts: News Release
-
Georgetown Breast Cancer Advocates Make Their Case in Cancer Research Journal
A group of breast cancer advocates at Georgetown Lombardi Comprehensive Cancer Center says they’ve created a model for developing productive, successful and sustainable collaborations between advocates and scientists in cancer research.
Category: News Release
-
NFLPA’s DeMaurice Smith Honored with Georgetown Lombardi Award for Steadfast Support of Cancer Research
Georgetown Lombardi Comprehensive Cancer Center has selected DeMaurice Smith, executive director of the NFL Players Association, to receive its annual leadership award recognizing his unwavering support of the Washington, D.C., cancer center.
Category: News Release
-
Large Collection of Brain Cancer Data Now Easily, Freely Accessible to Global Researchers
A valuable cache of brain cancer biomedical data, one of only two such large collections in the country, has been made freely available to researchers worldwide, say researchers at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
For Some Bladder Cancer Patients, Simple Test Could Reduce Overtreatment, Ease High Cost
A team of scientists led by Georgetown Lombardi Comprehensive Cancer Center researchers has published a study validating that a new test could be key to reducing the cost of caring for patients with bladder cancer while simultaneously relieving some patients of unnecessary treatment.
Category: News Release
-
Acclaimed Breast Oncologist/Researcher Returns to Georgetown’s Cancer Center
Physician-scientist Marc E. Lippman, MD, MACP, FRCP, rejoins Georgetown Lombardi Comprehensive Cancer Center as a member of the breast cancer program and will also be a professor in the departments of oncology and medicine at Georgetown University Medical Center.
Category: News Release
-
Family History Increases Breast Cancer Risk Even in Older Women: Weighing Screening Options
Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
A study led by Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center, that combined an agent that blocks blood vessel formation with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer who had not been previously treated.
Category: News Release
-
Unique Research Approach Finds FDA Approved Drug Shuts Down Ewing Sarcoma Cells in Lab
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
Category: News Release
-
Gene Test to Predict Breast Cancer Recurrence Less Cost Effective in Real World Practice
A team of researchers led by Georgetown Lombardi Comprehensive Cancer Center has published a study that indicates that the most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought.
Category: News Release
-
Georgetown Lombardi’s Jeffrey Toretsky, MD, Named a National Academy of Inventors Fellow
The National Academy of Inventors has named Jeffrey Toretsky, MD, a pediatric oncologist and researcher at Georgetown Lombardi Comprehensive Cancer Center, to its 2017 class of fellows.
Category: News Release